NCT05165979

Brief Summary

The present prospective cohort study aims to assess factors associated with of one-year health-related quality of life and physical, cognitive and mental health outcomes among adult survivors of hospitalization for COVID-19. Adult patients requiring hospitalization due to COVID-19 disease will be followed through structured and centralized telephone interviews performed at 3, 6, 9 and 12 months after enrollment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
650

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2021

Typical duration for all trials

Geographic Reach
1 country

24 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2021

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 21, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

December 21, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

November 7, 2023

Status Verified

November 1, 2023

Enrollment Period

2.3 years

First QC Date

December 20, 2021

Last Update Submit

November 3, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • One-year utility score of health related quality of life

    The outcome will be assessed using the Brazilian version of the Euroqol-5D-3L (EQ-5D3L) questionnaire.

    The outcome will be assessed 12 months after enrollment.

Secondary Outcomes (12)

  • Utility score of health related quality of life at 3, 6, and 9 months

    The outcome will be assessed at 3, 6, and 9 months after enrollment.

  • Incidence of all-cause mortality

    The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.

  • Incidence of major cardiovascular events

    The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.

  • Incidence of rehospitalizations

    The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.

  • Prevalence of prolonged COVID-19 symptoms

    The outcome will be assessed at 3, 6, 9, and 12 months after enrollment.

  • +7 more secondary outcomes

Study Arms (1)

Hospitalized COVID-19 patients

Hospitalized COVID-19 patients

Other: Hospitalization due to COVID-19

Interventions

Hospitalization due to COVID-19

Hospitalized COVID-19 patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients survivors of hospitalization due to proven COVID-19 disease.

You may qualify if:

  • Age ≥18 years;
  • Symptomatic COVID-19 disease within the last 14 days;
  • Positive polymerase chain reaction (PCR) test for SARS-CoV-2 within the last 14 days;
  • Need of hospitalization (duration ≥ 48 hours).

You may not qualify if:

  • Severe comorbidity with life expectancy less than 3 months;
  • Death during hospitalization;
  • Absence of telephone contact;
  • Absence of proxy for patients with communication difficulties;
  • Refusal or withdrawal of agreement to participate;
  • Previous enrollment in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (24)

Hospital do Coração de Mato Grosso do Sul

Campo Grande, Mato Grosso do Sul, Brazil

Location

Hospital das clínicas da UFMG

Belo Horizonte, Minas Gerais, Brazil

Location

Hospital Emydio Germano

Belo Horizonte, Minas Gerais, Brazil

Location

Hospital Metropolitano Célio de Castro

Belo Horizonte, Minas Gerais, Brazil

Location

Instituto Horizonti

Belo Horizonte, Minas Gerais, Brazil

Location

Santa Casa de Curitiba

Curitiba, Paraná, Brazil

Location

Hospital Universitário de Londrina

Londrina, Paraná, Brazil

Location

Hospital universitário de Ponta Grossa

Ponta Grossa, Paraná, Brazil

Location

Hospital Universitário de Canoas

Canoas, Rio Grande do Sul, Brazil

Location

Hospital Nelson Cornetet

Guaíba, Rio Grande do Sul, Brazil

Location

Hospital das Clínicas de Passo Fundo

Passo Fundo, Rio Grande do Sul, Brazil

Location

Hospital São Vicente de Paulo

Passo Fundo, Rio Grande do Sul, Brazil

Location

Fundação Universitária Instituto de Cardiologia

Porto Alegre, Rio Grande do Sul, Brazil

Location

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Location

Hospital Ernesto Dornelles

Porto Alegre, Rio Grande do Sul, Brazil

Location

Hospital moinhos de Vento

Porto Alegre, Rio Grande do Sul, Brazil

Location

Hospital Vila Nova

Porto Alegre, Rio Grande do Sul, Brazil

Location

Cemetron

Porto Velho, Rondônia, Brazil

Location

Hospital Leo Orsi

Itapetininga, São Paulo, Brazil

Location

Hospital Beneficência Portuguesa de Ribeirão Preto

Ribeirão Preto, São Paulo, Brazil

Location

Hospital Alemão Oswaldo Cruz

São Paulo, São Paulo, Brazil

Location

Hospital Beneficência Portuguesa de São Paulo

São Paulo, São Paulo, Brazil

Location

Hospital do Coração

São Paulo, São Paulo, Brazil

Location

Hospital SEPACO

São Paulo, São Paulo, Brazil

Location

Related Publications (1)

  • Trott G, Scolari FL, Rover MM, Silva MMDD, Souza D, Santos RDRMD, Schardosim RFC, Rech GS, Mesquita Neto J, Estivalete GP, Freitas HJM, Itaqui CR, Kozesinski-Nakatani AC, Biolo A, Marcolino MS, Barreto BB, Schvartzman PR, Antonio ACP, Robinson CC, Falavigna M, Polanczyk CA, Rosa RG. Long-term Health-Related Quality of Life and Outcomes after Hospitalization for COVID-19 in Brazil: Post-COVID Brazil 1 Study Protocol. Arq Bras Cardiol. 2023 Nov;120(11):e20230378. doi: 10.36660/abc.20230378. English, Portuguese.

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Regis G Rosa, MD, PhD

    Hospital Moinhos de Vento

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2021

First Posted

December 21, 2021

Study Start

December 21, 2021

Primary Completion

April 1, 2024

Study Completion

July 1, 2024

Last Updated

November 7, 2023

Record last verified: 2023-11

Locations